Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

A group of researchers used the golden hamster as a model system to better understand the long-term impacts of SARS-CoV-2 infection.

24 Jan 2022

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Researchers published a study exploring the possibilities of predisposing men for a life-threatening disease course of COVID-19.

24 Jan 2022

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

A new study aimed to study the incidence of SARS-CoV-2 infections in orchestra and choir musicians compared to controls.

24 Jan 2022

Novel SARS-CoV-2 mutations reported in chronic HIV patients

A new study describes the emergence of new SARS-CoV-2 variants in three immunocompromised patients.

23 Jan 2022

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Researchers assess the impact of the SARS-CoV-2 Omicron variant of concern on symptoms of SARS-CoV-2 infection.

23 Jan 2022

COVID-19 lockdowns depleted water quality of commercial building plumbing systems

Researchers evaluate how altered water demand in commercial and residential buildings deteriorated the water quality during the COVID-19 pandemic.

23 Jan 2022

Novel compound found in mussels helps increase the durability of dental fillings

Leading researchers from the Faculty of Dentistry, the University of Hong Kong, Wuhan University, and the Peking University Shenzhen Hospital have found that a compound found in mussels helps increase the durability of a dental filling.

22 Jan 2022

Antimicrobial resistance causes more deaths than HIV and malaria

Antibiotic-resistant bacterial infections resulted in more than 1.2 million deaths worldwide in 2019, exceeding the number caused by HIV/AIDS and malaria, says a study spanning 204 countries and territories.

22 Jan 2022

Omicron found to have higher environmental stability among SARS-CoV-2 variants

A new study compared the SARS-CoV-2 Wuhan strain and all the variants of concern (VOCs) - Alpha, Beta, Delta, and Omicron variants for their survivability and infectivity.

21 Jan 2022

Echinacea as a potential force against coronavirus infections

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.

21 Jan 2022

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

In a new study, researchers assessed the efficacy of the FDA-approved therapeutic mAbs, as well as to small-molecule antiviral agents against the SARS-CoV-2 Omicron variant in Syrian hamsters.

21 Jan 2022

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Several deadly pandemics have emerged in human history that have either disappeared or turned into epidemics. Researchers explored the likelihood that SARS-CoV-2 would also eventually become an endemic disease.

21 Jan 2022

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

The focus of this study was to investigate the evolution of PTSD symptoms in cancer patients over the first year of the COVID19 pandemic.

21 Jan 2022

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

New production method developed to freeze-dry COVID-19 vaccines

UMass Lowell scientists are developing a production method to freeze-dry COVID-19 vaccines activated by messenger-RNA so they can be transported and stored at room temperature.

21 Jan 2022

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet.

20 Jan 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Novel SARS-CoV-2 mutations reported in chronic HIV patients

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

COVID-19 lockdowns depleted water quality of commercial building plumbing systems

Novel compound found in mussels helps increase the durability of dental fillings

Antimicrobial resistance causes more deaths than HIV and malaria

Omicron found to have higher environmental stability among SARS-CoV-2 variants

Echinacea as a potential force against coronavirus infections

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

New COVID-19 vaccine promises vaccine equity because it has no patents

New production method developed to freeze-dry COVID-19 vaccines

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Study simulates transmission of SARS-CoV-2 in airliner cabins

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in